Literature DB >> 29392849

Risk of ESRD in prior living kidney donors.

Jennifer L Wainright1, Amanda M Robinson1, Amber R Wilk1, David K Klassen2, Wida S Cherikh1, Darren E Stewart1.   

Abstract

We studied End-Stage Renal Disease (ESRD) in living kidney donors (LKDs) who donated in the United States between 1994 and 2016 (n = 123 526), using Organ Procurement and Transplantation Network and Centers for Medicare and Medicaid Services data. Two hundred eighteen LKDs developed ESRD, with a median of 11.1 years between donation and ESRD. Absolute 20-year risk was low but not uniform, with risk associated with race, age, and sex and increasing exponentially over time. LKDs had increased risk of ESRD if they were male (adjusted hazard ratio [aHR]: 1.75, 95% confidence interval [95%CI]: 1.33-2.31), had higher BMI (aHR: 1.34 per 5 kg/m2 , 95%CI: 1.10-1.64) or lower estimated GFR (aHR: 0.89 per 10 mL/min, 95% CI: 0.80-0.99), were first-degree relatives of the recipient (parent: [aHR: 2.01, 95% CI: 1.26-3.21]; full sibling [aHR: 1.87, 95%CI: 1.23-2.84]; identical twin [aHR: 19.79, 95%CI: 7.65-51.24]), or lived in lower socioeconomic status neighborhoods at donation (aHR: 0.87 per $10k increase; 95%CI: 0.77-0.99). We found a significant interaction between donation age and race, with higher risk at older ages for white LKDs (aHR: 1.26 per decade, 95%CI: 1.04-1.54), but higher risk at younger ages for black LKDs (aHR: 0.75 per decade, 95%CI: 0.57-0.99). These findings further inform risk assessment of potential LKDs.
© 2018 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; donors and donation; donors and donation: living; ethics and public policy; ethnicity/race; kidney disease; kidney transplantation/nephrology; kidney transplantation: living donor

Mesh:

Year:  2018        PMID: 29392849     DOI: 10.1111/ajt.14678

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  24 in total

1.  ESKD Risk in Living Kidney Donors "Like Me".

Authors:  Kenneth A Newell; Richard N Formica
Journal:  Clin J Am Soc Nephrol       Date:  2019-06-25       Impact factor: 8.237

Review 2.  Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.

Authors:  Alejandra M Mena-Gutierrez; Amber M Reeves-Daniel; Colleen L Jay; Barry I Freedman
Journal:  Transplantation       Date:  2020-01       Impact factor: 4.939

Review 3.  Risks of Living Kidney Donation: Current State of Knowledge on Outcomes Important to Donors.

Authors:  Krista L Lentine; Ngan N Lam; Dorry L Segev
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 8.237

4.  Donor-Recipient Relationship and Risk of ESKD in Live Kidney Donors of Varied Racial Groups.

Authors:  Abimereki D Muzaale; Allan B Massie; Fawaz Al Ammary; Macey L Henderson; Tanjala S Purnell; Courtenay M Holscher; Jacqueline Garonzik-Wang; Jayme E Locke; Jon J Snyder; Krista L Lentine; Dorry L Segev
Journal:  Am J Kidney Dis       Date:  2019-11-12       Impact factor: 8.860

5.  Risk of kidney disease after living kidney donation.

Authors:  Arthur J Matas; Andrew D Rule
Journal:  Nat Rev Nephrol       Date:  2021-02-12       Impact factor: 28.314

6.  The changing landscape of live kidney donation in the United States from 2005 to 2017.

Authors:  Fawaz Al Ammary; Mary Grace Bowring; Allan B Massie; Sile Yu; Madeleine M Waldram; Jacqueline Garonzik-Wang; Alvin G Thomas; Courtenay M Holscher; Mohamud A Qadi; Macey L Henderson; Alexander C Wiseman; Jane Gralla; Daniel C Brennan; Dorry L Segev; Abimereki D Muzaale
Journal:  Am J Transplant       Date:  2019-05-03       Impact factor: 8.086

7.  Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.

Authors:  Allan B Massie; Courtenay M Holscher; Macey L Henderson; Lara M Fahmy; Alvin G Thomas; Fawaz Al Ammary; Samantha N Getsin; Jon J Snyder; Krista L Lentine; Amit X Garg; Dorry L Segev
Journal:  JAMA Surg       Date:  2020-03-18       Impact factor: 14.766

8.  Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant.

Authors:  Y Dana Neugut; Sumit Mohan; Ali G Gharavi; Krzysztof Kiryluk
Journal:  Ann Intern Med       Date:  2019-10-08       Impact factor: 25.391

9.  Social Determinants of Health and Race Disparities in Kidney Transplant.

Authors:  Hannah Wesselman; Christopher Graham Ford; Yuridia Leyva; Xingyuan Li; Chung-Chou H Chang; Mary Amanda Dew; Kellee Kendall; Emilee Croswell; John R Pleis; Yue Harn Ng; Mark L Unruh; Ron Shapiro; Larissa Myaskovsky
Journal:  Clin J Am Soc Nephrol       Date:  2021-01-28       Impact factor: 8.237

10.  The first increase in live kidney donation in the United States in 15 years.

Authors:  Fawaz Al Ammary; Yifan Yu; Alexander Ferzola; Jennifer D Motter; Allan B Massie; Sile Yu; Alvin G Thomas; Deidra C Crews; Dorry L Segev; Abimereki D Muzaale; Macey L Henderson
Journal:  Am J Transplant       Date:  2020-07-17       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.